Education
About Us
Working with TipRanks
Follow Us
Neil Herskowitz Insider Profile
18 Followers
Neil Herskowitz, Director at TG Therapeutics, holds 145.00 shares in Mustang Bio (Ticker: MBIO), holds 108.62K shares in Journey Medical Corp (Ticker: DERM), holds 0.00 shares in Checkpoint Therapeutics (Ticker: CKPT). Most recently, Neil Herskowitz Sold ― shares of Mustang Bio on Dec 30, 2025 for an estimated value of $237.12.
Profitable Transactions
10 out of 14 Profitable Transactions
Average Return
+31.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neil Herskowitz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 15, 2019 - Apr 15, 2020
Return:+101.00%
The most profitable trade made by Neil Herskowitz
Neil Herskowitz's Trading History
TG Therapeutics
Jun 10, 2014
Director
Uninformative Buy
―
$2.44M
Origo Acquisition Corporation
May 23, 2016
―
Uninformative Sell
―
$190.00K
National Holdings
―
―
―
$196.93K
Avenue Therapeutics
Dec 03, 2024
Director
Informative Sell
46.00
$72.75
Checkpoint Therapeutics
May 30, 2025
―
Uninformative Sell
―
$0.00
Mustang Bio
Dec 30, 2025
Director
Informative Sell
237.12
$165.30
Journey Medical Corp
Aug 07, 2025
Director
Uninformative Buy
―
$794.00K
List of latest transactions for each holding click on a transaction to see Neil Herskowitz's performance on stock
You May Also Like
Neil Herskowitz insider profile FAQ
What is the percentage of profitable transactions made by Neil Herskowitz?
The percentage of profitable transactions made by Neil Herskowitz is 71%.
What is the average return per transaction made by Neil Herskowitz?
The average return per transaction made by Neil Herskowitz is 31.10%.
What stocks does Neil Herskowitz hold?
Neil Herskowitz holds: TGTX, OACQF, NHLD, ATXI, CKPT, MBIO, DERM stocks.
What was Neil Herskowitz’s latest transaction?
Neil Herskowitz latest transaction was an Informative Sell of $237.12.
What was Neil Herskowitz's most profitable transaction?
Neil Herskowitz’s most profitable transaction was an Informative Buy of ATXI stock on April 15, 2019. The return on the trade was 101.00%.
What is Neil Herskowitz's role in TG Therapeutics?
Neil Herskowitz's role in TG Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.